News
06-07-2011, 12:50 AM
Circadian Technologies Limited announced today the presentation of data at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago USA associating resistance to Avastin with increases in plasma VEGF-C and D concentrations.
More... (http://www.news-medical.net/news/20110607/Increases-in-VEGF-family-markers-in-metastatic-colorectal-cancer-patients-associated-with-Avastin-resistance.aspx)
More... (http://www.news-medical.net/news/20110607/Increases-in-VEGF-family-markers-in-metastatic-colorectal-cancer-patients-associated-with-Avastin-resistance.aspx)